ARTICLES BY RAY SISON

• CDMO Selection In Our Post-COVID World

  10/28/2022

  In a post-pandemic world, we need to explore a broader view of our new reality. This article shares some of the concepts currently playing out in bio/pharmaceutical outsourcing that will impact your CDMO selection strategy. Additional discussion touches on how new outsourcing players will fit in and the path forward.

• 2 Things Every Emerging Biopharma Needs To Know About Supply Chain

  5/8/2020

  For clinicians on the front lines with potential effective therapies who are exploring how to develop new drug products, as well as development-stage companies looking to manage clinical supply chains and transform their organization for product launch, a basic framework is needed in order to integrate supply chain operation into a business strategy.

• How To Ace Your Next CDMO Capabilities Audit

  6/18/2019

  Site visits require a significant investment of resources on the part of both a sponsor and its prospective CDMO, so swapping out the time required to prep, travel, meet, and follow up in favor of a two-hour teleconference is understandable … to a limited extent.

• CDMO Selection: 3 Questions To Save Time And Reduce Stress When Reviewing An MSA

  4/9/2019

  Whether because of unfamiliarity or lack of resources, master service or supply agreement (MSA) execution can be time consuming and difficult.